Cancer-Causing HPV Infection Linked to Increased Risk Of HIV Infection

by Tanya Thomas on  May 4, 2009 at 10:20 AM AIDS/HIV News
RSS Email Print This Page Comment bookmark
Font : A-A+

 Cancer-Causing HPV Infection Linked to Increased Risk Of HIV Infection
A recent study has discovered a link between anal human papillomavirus (HPV) infection (a virus known to cause anal and cervical cancers) and higher risk of new HIV infection in previously HIV-negative men when they have sex with men (MSM).

Previous studies have associated other sexually transmitted infections to higher risk of HIV infection and HPV is the most common sexually transmitted infection.

"We looked at HIV-negative men who have sex with men who were at high risk for HIV infection and who had multiple risk factors. Our results showed a strong independent association for increased risk of HIV acquisition among those men who were already infected with anal HPV," said the study's lead investigator, Peter V. Chin-Hong, MD, associate professor of clinical medicine and director of the program in transplant and immunocompromised host infectious diseases at UCSF.

The 1400 study participants were part of the EXPLORE trial, a large clinical trial to test the efficacy of a behavioral intervention for HIV-negative MSM with sites in Boston, Denver, New York and San Francisco. Risk factors were calculated from those men who became HIV-infected over the course of the trial and infections were identified by blood tests.

"We think that HPV enhances susceptibility to HIV infection through two mechanisms. Anatomically, the virus causes anal lesions. These lesions bring blood vessels closer to the surface and also the lesions' skin layer is thinner and more easily shredded, which frequently causes bleeding. These disruptions of the mucosal barrier could allow easier entry for HIV," said Chin-Hong.

Also, HPV activates the immune system. The inflammatory cells recruited to the HPV lesions-dendritic cells, macrophages and CD4 T cells-are the immune cells most susceptible to HIV infection.

HPV vaccine has been found effective in preventing acquisition of the virus by women. Clinical trials testing the effectiveness of the vaccine among MSM are currently under way.

The study's senior investigator and author, Joel Palefsky, MD, professor of medicine and director of the Anal Neoplasia Clinic at UCSF, said: "To date, the focus of attention on HPV has been almost exclusively on its key role in causing squamous cell cancer. This study points to another important means by which HPV infection may be associated with morbidity and mortality, i.e., through potentiation of HIV infection.

"A direct role for HPV in this process will need to be confirmed in additional studies, and additional studies will be needed to understand the mechanisms by which HPV may do this," he added

The study has been reported online ahead of print in the journal AIDS.

Source: ANI
TAN/L

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Cervical Cancer Prostitution: Fresh Stakes in the Oldest Trade 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive